06 Jul 2021 --- Swedish probiotics company Probi is investing approximately NZ$9 million (US$6.4 million) in newly issued shares in Blis Technologies, a New Zealand probiotics company. Blis has clinically documented bacterial strains to support natural immune defenses, preventing mouth and throat infections. The strains also contribute to dental and gum health.
